{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:14:20Z","timestamp":1791288860822,"version":"4.3.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Despite growing evidence for the roles of airway remodeling and bacterial infection in the progression of non\u2013cystic fibrosis bronchiectasis, relationships between collagen-degrading proteases and chronic airway infection are poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The aim of this study was to determine which matrix metalloproteinases (MMPs) are elevated in bronchiectasis, whether these MMP levels vary based on patients\u2019 dominant infective microbe, and how these levels correlate with clinical measures of disease severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We determined concentrations of nine MMPs and four tissue inhibitors of metalloproteinases (TIMPs) in induced sputum from 86 patients with bronchiectasis and 8 healthy control subjects by Luminex protein assay. Concentrations were then assessed in relation to lung function, inflammatory markers, and airway microbiota composition, determined by 16S rRNA gene amplicon sequencing. Airway microbiota composition was classified as Pseudomonas aeruginosa\u2013dominated, Haemophilus influenzae\u2013dominated, or dominated by another species. MMP-8 and MMP-9 activity levels were also measured in a subset of patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>MMP-1, -3, -7, -8, and -9 and TIMP-2 and -4 levels, as well as MMP-8\/TIMP-1 and MMP-9\/TIMP-1 ratios, were significantly higher in patients with bronchiectasis than in healthy control subjects (all: P\u2009&amp;lt;\u20090.001, except MMP-7: P\u2009&amp;lt;\u20090.05). Patients with bronchiectasis with H. influenzae\u2013dominated airway infections demonstrated higher MMP-2 levels (P\u2009&amp;lt;\u20090.01) and MMP-8 activity (P\u2009&amp;lt;\u20090.05) than those with P. aeruginosa\u2013dominated airway infections. Among patients with bronchiectasis, there were significant inverse correlations between FEV1 as a percentage of predicted value, MMP-8 and MMP-1 levels, and MMP-8\/TIMP-1 and MMP-9\/TIMP-1 ratios (P\u2009&amp;lt;\u20090.01).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Increased MMP levels (particularly MMP-8 and MMP-1) and MMP\/TIMP ratios in patients with bronchiectasis compared with healthy control subjects correlated with lower lung function and higher levels of inflammatory markers. Further, MMP profiles differed in patients with bronchiectasis according to the dominant pathogen determined by gene sequencing, raising the possibility of differential airway remodeling according to airway microbiology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.201411-513oc","type":"journal-article","created":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T10:21:22Z","timestamp":1423822882000},"page":"701-707","source":"Crossref","is-referenced-by-count":95,"title":["Matrix Metalloproteinases Vary with Airway Microbiota Composition and Lung Function in Non\u2013Cystic Fibrosis Bronchiectasis"],"prefix":"10.1093","volume":"12","author":[{"given":"Steven L.","family":"Taylor","sequence":"first","affiliation":[{"name":"Immunity, Infection, and Inflammation Program, Mater Research Institute, University of Queensland and Translational Research Institute, Woolloongabba, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraint B.","family":"Rogers","sequence":"additional","affiliation":[{"name":"SAHMRI Infection and Immunity Theme, School of Medicine, Flinders University, Bedford Park, Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice C.-H.","family":"Chen","sequence":"additional","affiliation":[{"name":"Immunity, Infection, and Inflammation Program, Mater Research Institute, University of Queensland and Translational Research Institute, Woolloongabba, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy D.","family":"Burr","sequence":"additional","affiliation":[{"name":"Immunity, Infection, and Inflammation Program, Mater Research Institute, University of Queensland and Translational Research Institute, Woolloongabba, Australia"},{"name":"Department of Respiratory Medicine, Mater Adult Hospital, South Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"McGuckin","sequence":"additional","affiliation":[{"name":"Immunity, Infection, and Inflammation Program, Mater Research Institute, University of Queensland and Translational Research Institute, Woolloongabba, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Serisier","sequence":"additional","affiliation":[{"name":"Immunity, Infection, and Inflammation Program, Mater Research Institute, University of Queensland and Translational Research Institute, Woolloongabba, Australia"},{"name":"Department of Respiratory Medicine, Mater Adult Hospital, South Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,5,1]]},"reference":[{"key":"2026012303393845100_bib1","first-page":"6","article-title":"Inflammation: a two-edged sword\u2014the model of bronchiectasis","volume":"147","author":"Cole","year":"1986","journal-title":"Eur J Respir Dis Suppl"},{"key":"2026012303393845100_bib2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1164\/rccm.201203-0487OC","article-title":"Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis","volume":"186","author":"Chalmers","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303393845100_bib3","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.rmed.2007.03.009","article-title":"Microbiologic follow-up study in adult bronchiectasis","volume":"101","author":"King","year":"2007","journal-title":"Respir Med"},{"key":"2026012303393845100_bib4","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1164\/rccm.201210-1937OC","article-title":"Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation","volume":"187","author":"Tunney","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303393845100_bib5","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/thoraxjnl-2012-203105","article-title":"Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition","volume":"68","author":"Rogers","year":"2013","journal-title":"Thorax"},{"key":"2026012303393845100_bib6","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1513\/AnnalsATS.201310-335OC","article-title":"A novel microbiota stratification system predicts future exacerbations in bronchiectasis","volume":"11","author":"Rogers","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"2026012303393845100_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/ismej.2014.124","article-title":"Predominant pathogen competition and core microbiota divergence in chronic airway infection","volume":"9","author":"Rogers","year":"2015","journal-title":"ISME J"},{"key":"2026012303393845100_bib8","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1378\/chest.114.6.1594","article-title":"The effect of Pseudomonas aeruginosa infection on clinical parameters in steady-state bronchiectasis","volume":"114","author":"Ho","year":"1998","journal-title":"Chest"},{"key":"2026012303393845100_bib9","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1183\/09031936.96.09081601","article-title":"Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa","volume":"9","author":"Evans","year":"1996","journal-title":"Eur Respir J"},{"key":"2026012303393845100_bib10","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.rmed.2006.11.008","article-title":"Aetiology in adult patients with bronchiectasis","volume":"101","author":"Shoemark","year":"2007","journal-title":"Respir Med"},{"key":"2026012303393845100_bib11","doi-asserted-by":"crossref","first-page":"e0119325","DOI":"10.1371\/journal.pone.0119325","article-title":"Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal th17 pathway activation","volume":"10","author":"Chen","year":"2015","journal-title":"PloS One"},{"key":"2026012303393845100_bib12","doi-asserted-by":"crossref","first-page":"L709","DOI":"10.1152\/ajplung.00418.2012","article-title":"Always cleave up your mess: targeting collagen degradation to treat tissue fibrosis","volume":"304","author":"McKleroy","year":"2013","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012303393845100_bib13","first-page":"1","article-title":"Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis","volume":"6","author":"Bergin","year":"2013","journal-title":"J Inflamm Res"},{"key":"2026012303393845100_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejphar.2005.12.082","article-title":"Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases","volume":"533","author":"Gueders","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"2026012303393845100_bib15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1034\/j.1600-0463.2002.1101102.x","article-title":"Soluble membrane-type 1 matrix metalloproteinase (MT1-MMP) and gelatinase A (MMP-2) in induced sputum and bronchoalveolar lavage fluid of human bronchial asthma and bronchiectasis","volume":"110","author":"Maisi","year":"2002","journal-title":"APMIS"},{"key":"2026012303393845100_bib16","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1053\/rmed.2001.1155","article-title":"Macrophages, neutrophils and tumour necrosis factor-alpha expression in bronchiectatic airways in vivo","volume":"95","author":"Zheng","year":"2001","journal-title":"Respir Med"},{"key":"2026012303393845100_bib17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/thx.2005.051979","article-title":"Matrix metalloproteinases in destructive pulmonary pathology","volume":"61","author":"Elkington","year":"2006","journal-title":"Thorax"},{"key":"2026012303393845100_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0945-053X(01)00175-5","article-title":"Differential regulation of MMP-1\/9 and TIMP-1 secretion in human monocytic cells in response to Mycobacterium tuberculosis","volume":"21","author":"Friedland","year":"2002","journal-title":"Matrix Biol"},{"key":"2026012303393845100_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2119\/molmed.2009.00109","article-title":"Human neutrophil elastase-mediated cleavage sites of MMP-9 and TIMP-1: implications to cystic fibrosis proteolytic dysfunction","volume":"16","author":"Jackson","year":"2010","journal-title":"Mol Med"},{"key":"2026012303393845100_bib20","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/01.CCM.0000048626.02184.F8","article-title":"Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients","volume":"31","author":"Lanchou","year":"2003","journal-title":"Crit Care Med"},{"key":"2026012303393845100_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jinf.2009.05.004","article-title":"Matrix metalloproteases in bronchoalveolar lavage fluid of patients with type III Pseudomonas aeruginosa pneumonia","volume":"59","author":"El-Solh","year":"2009","journal-title":"J Infect"},{"key":"2026012303393845100_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1034\/j.1398-9995.2001.056002145.x","article-title":"Matrix metalloproteinases and TIMP-1 production by peripheral blood granulocytes from COPD patients and asthmatics","volume":"56","author":"Cataldo","year":"2001","journal-title":"Allergy"},{"key":"2026012303393845100_bib23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000242362","article-title":"Effects of inhaled corticosteroids on metalloproteinase-8 and tissue inhibitor of metalloproteinase-1 in the airways of asthmatic children","volume":"151","author":"Obase","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"2026012303393845100_bib24","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1164\/ajrccm.158.6.9803014","article-title":"Sputum metalloproteinase-9\/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis","volume":"158","author":"Vignola","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303393845100_bib25","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0091-6749(98)70018-1","article-title":"Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation","volume":"102","author":"Hoshino","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"2026012303393845100_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/resp.12219","article-title":"The Sputum Colour Chart as a predictor of lung inflammation, proteolysis and damage in non-cystic fibrosis bronchiectasis: a case\u2013control analysis","volume":"19","author":"Goeminne","year":"2014","journal-title":"Respirology"},{"key":"2026012303393845100_bib27","doi-asserted-by":"crossref","first-page":"e66265","DOI":"10.1371\/journal.pone.0066265","article-title":"Matrix metalloproteinase-1 polymorphism (\u22121607G) and disease severity in non-cystic fibrosis bronchiectasis in Taiwan","volume":"8","author":"Hsieh","year":"2013","journal-title":"PLoS One"},{"key":"2026012303393845100_bib28","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/ppul.21096","article-title":"Exhaled breath condensate MMP-9 levels in children with bronchiectasis","volume":"44","author":"Karakoc","year":"2009","journal-title":"Pediatr Pulmonol"},{"key":"2026012303393845100_bib29","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/path.849","article-title":"In vivo collagenase-2 (MMP-8) expression by human bronchial epithelial cells and monocytes\/macrophages in bronchiectasis","volume":"194","author":"Prikk","year":"2001","journal-title":"J Pathol"},{"key":"2026012303393845100_bib30","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1378\/chest.107.6.1641","article-title":"Human neutrophil collagenase (MMP-8), identified in bronchiectasis BAL fluid, correlates with severity of disease","volume":"107","author":"Sepper","year":"1995","journal-title":"Chest"},{"key":"2026012303393845100_bib31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1183\/09031936.02.00282402","article-title":"Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo","volume":"20","author":"Zheng","year":"2002","journal-title":"Eur Respir J"},{"key":"2026012303393845100_bib32","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.2013.2290","article-title":"Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial","volume":"309","author":"Serisier","year":"2013","journal-title":"JAMA"},{"key":"2026012303393845100_bib33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/JCM.01324-09","article-title":"Determining cystic fibrosis-affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling","volume":"48","author":"Rogers","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2026012303393845100_bib34","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S2213-2600(14)70213-9","article-title":"The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial","volume":"2","author":"Rogers","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2026012303393845100_bib35","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1172\/JCI45666","article-title":"MMP-1 drives immunopathology in human tuberculosis and transgenic mice","volume":"121","author":"Elkington","year":"2011","journal-title":"J Clin Invest"},{"key":"2026012303393845100_bib36","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1164\/rccm.201110-1769OC","article-title":"Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases","volume":"185","author":"Walker","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303393845100_bib37","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1165\/ajrcmb\/7.2.120","article-title":"The matrix metalloproteinases and their inhibitors","volume":"7","author":"Murphy","year":"1992","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012303393845100_bib38","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1164\/ajrccm.162.5.9906096","article-title":"Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias","volume":"162","author":"Suga","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303393845100_bib39","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1183\/09031936.00007109","article-title":"Pneumolysin induces release of matrix metalloproteinase-8 and -9 from human neutrophils","volume":"34","author":"Cockeran","year":"2009","journal-title":"Eur Respir J"},{"key":"2026012303393845100_bib40","doi-asserted-by":"crossref","first-page":"L96","DOI":"10.1152\/ajplung.00492.2006","article-title":"Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients","volume":"293","author":"Gaggar","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/12\/5\/701\/66488405\/annalsats_12_5_701.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/12\/5\/701\/66488405\/annalsats_12_5_701.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:39:47Z","timestamp":1769157587000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/12\/5\/701\/8429338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,1]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,1]]},"published-print":{"date-parts":[[2015,5,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201411-513oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,5]]},"published":{"date-parts":[[2015,5,1]]}}}